8 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
7d
Article Searches
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk? https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001 Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Wall Street Awaits Consumer Confidence Data https://www.zacks.com/stock/news/2246106/wall-street-awaits-consumer-confidence-data?cid=CS-ZC-FT-economic_highlights-2246106 Mar 26, 2024 - Wall Street Awaits Consumer Confidence Data
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data https://www.zacks.com/stock/news/2246931/viking-vktx-up-17-on-encouraging-oral-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246931 Mar 27, 2024 - Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club? https://www.fool.com/investing/2024/03/28/eli-lilly-vs-berkshire-hathaway-which-stock-will-b/?source=iedfolrf0000001 Mar 28, 2024 - Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings https://www.zacks.com/stock/news/2245863/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245863 Mar 26, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297 Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run https://www.fool.com/investing/2024/03/28/bull-market-buys-3-dividend-stocks-to-own-for-the/?source=iedfolrf0000001 Mar 28, 2024 - Invest in stability, dividends, and growth with these three accomplished real estate operators.
Stock-Split Watch: Are These 2 Top Growth Stocks Next? https://www.fool.com/investing/2024/03/28/stock-split-watch-are-these-2-top-growth-stocks/?source=iedfolrf0000001 Mar 28, 2024 - Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.

Pages: 1

Page 1